Trinucleotide expansions cause disease by both protein-and RNAmediated mechanisms. Unexpectedly, we discovered that CAG expansion constructs express homopolymeric polyglutamine, polyalanine, and polyserine proteins in the absence of an ATG start codon. This repeat-associated non-ATG translation (RAN translation) occurs across long, hairpin-forming repeats in transfected cells or when expansion constructs are integrated into the genome in lentiviral-transduced cells and brains. Additionally, we show that RAN translation across human spinocerebellar ataxia type 8 (SCA8) and myotonic dystrophy type 1 (DM1) CAG expansion transcripts results in the accumulation of SCA8 polyalanine and DM1 polyglutamine expansion proteins in previously established SCA8 and DM1 mouse models and human tissue. These results have implications for understanding fundamental mechanisms of gene expression. Moreover, these toxic, unexpected, homopolymeric proteins now should be considered in pathogenic models of microsatellite disorders.
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bidirectional expression | neurodegeneration | translation initiation T ranslation of mRNA into protein is an exquisitely regulated, almost error-free process. Well-established rules of translational initiation have been used as a cornerstone in biology to understand gene expression and to predict the consequences of disease-causing mutations (1) . For microsatellite expansion disorders, mutations within or outside ATG-initiated ORFs are thought to cause disease either by protein gain-of-function, protein loss-of-function, or RNA gain-of-function mechanisms (2, 3) .
Microsatellite expansion mutations that express polyglutamine (polyGln) expansion proteins include Huntington disease (Huntingtin, HD), spinal bulbar muscular atrophy, and spinocerebellar ataxia types 1, 2, 3, 6, 7, and 17. Since the discovery of these CAG·CTG expansion mutations, efforts to understand disease mechanisms have focused on elucidating the molecular effects of the polyGln proteins expressed from these loci. Although these polyGln expansion proteins bear no similarity to each other apart from the polyGln tract, a hallmark of these diseases is protein accumulation and aggregation in nuclear or cytoplasmic inclusions. Surprisingly, although the polyGln expansion proteins are widely expressed in the CNS and other tissues, only restricted populations of neurons are vulnerable in each disease (3) .
Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are the best-characterized examples of RNA-mediated expansion disorders (2) . The mutation causing DM1 is a CTG-repeat expansion located in the 3′ UTR of the dystrophia myotonica-protein kinase (DMPK) gene. Although DM1 can be clinically more severe than DM2, the discovery of the DM2 mutation and several mouse models provide strong support that many features of these diseases result from RNA gain-of-function effects in which the dysregulation of RNA-binding proteins is mediated by the expression of CUG and CCUG transcripts (4) . Additionally, RNA gain-of-function effects have been reported for CGG and CAG expansion RNAs (5, 6) .
Both RNA and protein mechanisms appear to operate in spinocerebellar ataxia type 8 (SCA8) because the CTG·CAG expansion mutation is expressed in both the CUG (ataxin 8 opposite strand, AXN8OS) and CAG (ataxin 8, ATXN8) directions. ATXN8 expansion transcripts express polyGln protein from an ATG-initiated ORF, and both polyGln protein (7) and AXN8OS CUG EXP transcripts (8) accumulate in affected cells.
Results
To understand the role of the ATXN8 polyGln protein in SCA8, we mutated the only ATG initiation codon located 5′of the CAG expansion on an ATXN8 (A8) minigene. Unexpectedly, we found this mutation did not prevent expression of the polyGln expansion protein in transfected cells (Fig. 1A) . Sequence analysis showed that neither full-length nor spliced transcripts, which are expressed at approximately equal ratios from the (−)ATG minigene, are predicted to contain an AUG initiation codon (Fig.  S1A ). To test if non-ATG translation also could occur in other frames, a triply-tagged A8 minigene, A8(*KKQ EXP )-3Tf1, was generated by inserting a 6X STOP codon cassette (two stops in each frame) upstream of the CAG EXP and three different Cterminal tags to monitor protein expression in all frames [i.e., CAG glutamine (Gln); AGC serine (Ser); and GCA alanine (Ala)] (Fig. 1B) . Surprisingly, although transcripts generated from this tagged construct were confirmed to lack initiator AUG codons ( Fig. S1B) by RT-PCR, tagged polyGln, polyAla, and polySer proteins were expressed (Fig. 1B) in transfected cells.
The polyGln expansion proteins migrated at one or more discrete molecular weights, polyAla as a high molecular weight smear with a faint laddering pattern seen on light exposures, and polySer at the top of polyacrylamide gels in SDS (Fig. 1B ) or 8 M urea (Fig. S2A ). As expected, these proteins were degraded by proteinase K, were not affected by RNase I or DNase I, and were not detected with addition of cycloheximide (Fig. 1B) . The rel-ative levels of polyGln expressed with and without an ATG codon are similar (Fig 1 A and B) . To compare the relative levels of the polyGln, polyAla, and polySer, each was tagged with the same HA epitope. The protein blot shown in Fig. 1C indicates that polyAla is expressed at the highest levels, followed by polyGln and then polySer. Immunofluorescence (IF) shows these proteins can be expressed simultaneously in a single cell and that relative levels in individual cells can vary dramatically (Fig. 1D  and Fig. S2B ). Consistent with previous reports, the polyGln protein is localized primarily within the nuclear aggregates (3), the polyAla protein is primarily diffuse when in the cytoplasm and aggregated when nuclear (9, 10) , and the polySer protein forms both nuclear and cytoplasmic aggregates (9) . Additionally, an ATG start codon in the polyGln frame variably resulted in an additional higher molecular weight band, suggesting that translational initiation occurs at the ATG and one or more additional sites in some sequence contexts [compare polyGln for A8(*KMQ EXP )-endo and A8(*KMQ EXP )-3Tf1 ( Fig. 1 A and B) ].
To determine if this repeat-associated non-ATG (RAN) translation is affected by sequence context, we modified the A8 (*KKQ EXP )-3Tf1 construct by removing 90 bp of the ATXN8 sequence so that the 6X STOP cassette was almost adjacent to the CAG EXP and by adding a seventh STOP immediately upstream of the polyGln, polyAla, or polySer frames (Fig. S3 ). These constructs also expressed polyGln and polyAla but only low levels of polySer, with the exception that a TAG stop immediately preceding the glutamine frame prevented translation of polyGln but not of polyAla or polySer.
Because these results were completely unexpected, we used several approaches to establish the identity of these homopolymeric proteins. First, each protein was detected with one or more C-terminal epitope tags (myc, His, and HA for Gln; HA for Ala; and HA and Flag for Ser), and the polyGln protein was detected with a monoclonal antibody (1C2) specific to polyGln expansion tracts ( Fig. 1) Immunoprecipitations were performed using α-HA antibody, separated by PAGE on duplicate gels and detected by either immunoblot or fluorography. Fig. 2A Upper shows that all three proteins in each set were pulled down by immunoprecipitation, and the corresponding fluorograph ( Fig. 2A Lower) Third, we used MS to confirm that RAN translation results in the expression of a polyAla expansion protein. PolyAla was selected for MS because (i) polyAla-specific antibodies are not available, and (ii) the putative polyAla protein is expressed at sufficiently high levels required for MS in transfected cells. An arginine residue was introduced into the recombinant protein so that trypsin digestion of the N terminus would generate smaller peptide fragments of suitable size for MS (Fig. 2B) . IntR (GCA EXP )-3T lysates were separated by PAGE, and MS was performed on proteins isolated from gel slices A1-A7 (Fig. 2C) . Associated mass spectra were submitted for database searching against a human protein database and a list of all possible polyAla proteins in which translation could begin before or within the repeat and for which initiation would allow the possible inclusion of an N-terminal methionine residue. MS/MS identified a series of N-terminal peptides with varying numbers of alanines [(A) 9-17 R and AAADLEITR] (Fig. 2 D and E) . No peptides containing N-terminal methionine were detected, suggesting that translation initiation in cells occurs without incorporating an N-terminal methionine or that it is removed rapidly by methionine aminopeptidase or endopeptidase activity (12) . Additionally, the predicted C-terminal digestion fragment (TTTT-SSYPYDVPDYA) was identified (Fig. S4) . In summary, these results demonstrate that RAN translation results in polyAla expression in transfected cells and that these proteins run as a broad smear on SDS-PAGE. To test if transcripts undergoing RAN translation are modified or edited, resulting in the introduction of AUG initiation codons, we isolated and characterized mRNA from actively translating polyribosomes isolated from cells transfected with (CAG EXP )-3T constructs with or without an ATG initiation codon (Fig. 3A) . Northern analysis showed that transcripts expressed from both the (+)ATG and (−)ATG constructs migrated at the predicted size (∼700 nt) and cosedimented with light polyribosomal fractions (Fig. 3B) . Further characterization of ribosome-bound CAG EXP transcripts from fraction six by 5′ RACE and RT-PCR show that (i) transcription initiated within a few bp of the predicted transcription start site and (ii) the sequence predicted by the DNA was found in the corresponding transcripts and that no upstream AUG initiation codons were introduced by RNA splicing or editing among 140 independently isolated clones (Fig. 3C ). To rule out independently the possibility that +ATG transcripts might be generated from these plasmids by a cryptic promoter or alternative splicing, RNA transfections were performed. We transcribed RNA in vitro from the ATT(CAG EXP ) construct and two additional linearized non-ATG constructs and transfected the RNA into cells. Consistent with previous results, RAN translation of polyGln protein also occurred with cell-free-generated RNA (Fig. 3D) .
To test if RAN translation depends on repeat length, constructs containing 15-107 CAGs were examined. Constructs with 42-107 CAGs express polyGln by RAN translation, but constructs with 15 or 20 CAGs did not ( Fig. 4A and Fig. S5 A and B) . PolyAla was robustly expressed with 105 and 107 CAGs, moderately with 73 and 78 CAGs, and not with 42 and 58 CAGs. PolySer was detected with 58-107 repeats but not with 42 repeats (Fig. 4A) . Thus, RAN translation is length dependent, and longer repeat tracts are associated with the simultaneous expression of multiple proteins. Because both repeat length and secondary hairpin structures are associated with CAG and several other disease-causing microsatellite expansions, we compared RAN translation of polyGln expansion proteins expressed from constructs containing hairpinforming CAG and non-hairpin-forming CAA repeats. Cells transfected with CAG expansion constructs with or without ATG start codons expressed polyGln (Fig. 4B) . In contrast, polyGln was expressed only from the CAA expansion constructs with an ATG start codon, suggesting that hairpin formation is required for RAN translation. All constructs were confirmed to express transcripts by RT-PCR (Fig. S5C) . Because CUG EXP transcripts also form hairpin structures, we tested CTG EXP constructs and show that RAN translation also occurs in all three frames (polyleucine, polyAla, and polycystine) (Fig. S5D) .
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Next, we addressed if RAN-translation products trigger apoptosis and therefore could be implicated in disease pathogenesis. Murine neuroblastoma (N2a) cells transfected with ATT (CAG 105 )-3T and ATG(CAG 105 )-3T, which express polyGln, polyAla, and polySer, showed significant increases in annexin-V staining (13), compared with control cells (Fig. 4C and Fig. S5E ). These results indicate that the products of RAN translation can cause apoptosis.
Because most disease-causing CAG·CTG expansions are found in larger polyGln ORFs, we tested if RAN translation in the polyAla and polySer frames would still occur in the presence of an ATG-initiated polyGln ORF (Fig. 5 A and B) . PolyAla and polySer proteins were expressed irrespective of the polyGln ORF. The absence of the V5-tag on the polyGln from the (−)ATG V5 construct demonstrates RAN translation of polyGln initiated downstream of the V5 tag and close to, or within, the repeat. Immunoprecipitation using antibodies to 3′epitopes followed by immunoblot with α-V5 showed only a small fraction of polyAla protein has undergone frame shifting from the ATG-initiated V5-polyGln frame (Fig. 5C ). Although previously frame shifting has been suggested to result in hybrid polyGln-polyAla and polyGlnpolySer proteins in spinocerebellar ataxia type 3 (SCA3) and Huntington disease (14, 15) , our data demonstrate that frame shifting is rare, and an out-of-frame ATG initiation codon is not required for polyAla or polySer expression.
The potential for RAN translation in other disease-relevant sequence contexts was investigated using constructs with 20 bp of 5′ flanking sequence upstream of the CAG repeat from the HD, Huntingtin-like 2 (HDL2), SCA3, or DM1 loci (Fig. S6A ). These constructs showed robust polyGln and polyAla and variable polySer expression with the highest non-ATG polySer translation for A8(*KKQ EXP ) and HDL2 (Fig. S6B) . RT-PCR confirmed that each construct expressed unspliced transcripts with ATGinitiated ORFs only in the glutamine and serine frames for A8 (*KMQ EXP ) and DM1 constructs, respectively.
To understand better the conditions required for expression of these homopolymeric expansion proteins, we performed lentiviral transductions of HEK293T cells and mouse brain. Similar to the transfections described above, RAN translation of polyGln and polyAla also occurs in lentiviral-transduced cells and intact mouse brain (Fig. S6 C-E) . Taken together, these data demonstrate that RAN translation can occur when the transgene is integrated into the genome and that CAG expansions located in a variety of sequence contexts and under a variety of conditions can express homopolymeric expansion proteins in the absence of an ATG-start codon.
Next, rabbit reticulocyte lysates (RRLs) were used to test if non-ATG translation also occurs in a cell-free system. In contrast to cells, RAN translation in RRLs was limited. Only HDL2 produced polyGln without an ATG, none of the constructs generated detectable polyAla, and the highest levels of non-ATG-initiated polySer were from the HD and SCA3 constructs (Fig. S7A) . Moreover, RAN translation in RRLs, but not in cells, is substantially affected by mutating previously reported alternative initiation codons (ATT and ATC) (16, 17) (Fig. S7 B-D) , indicating that sequence requirements for RAN translation in RRLs are less permissive than in cells. Next, we used constructs that undergo non-ATG translation in RRLs to test if N-terminal methionine incorporation still occurs in the absence of an AUG initiation codon. We showed that polyGln expressed from constructs lacking initiator and internal methionine codons incorporated S 35 -methionine ( because we were not able to detect N-terminal methionine for any of the polyAla proteins using MS.
To determine if novel homopolymeric proteins are expressed in vivo, we developed peptide antibodies to putative RANtranslated SCA8-polyAla (SCA8 GCA-Ala ) and DM1 polyGln (DM1 CAG-Gln ) proteins ( Fig. 6 A and E). The specificity of both the α-SCA8 GCA-Ala and α-DM1 CAG-Gln antibodies was demonstrated by Western blot and IF detection in cells expressing recombinant SCA8 GCA-Ala and DM1 CAG-Gln proteins but not in control cells (Fig. 6 B and F) . Consistent with the possible role for RAN-translated proteins in SCA8, we detected α-SCA8 GCA-Ala immunostaining in Purkinje cell soma and dendrites throughout the cerebellum in an established SCA8 mouse model (7) (Fig. 6C) . Similarly, α-SCA8 GCA-Ala staining was found reproducibly in the remaining cerebellar Purkinje cells of postmortem samples from two patients with SCA8 (e.g., Fig 6D) . For myotonic dystrophy, IF staining of DM1 mice (18) which express CUG EXP ( Fig. S8A ) and CAG EXP transcripts ( Fig. S8 B and C) show rare (2.32 ± 2.04%) but reproducible α-DM1 CAG-Gln nuclear aggregates in cardiac myocytes ( Fig. 6G and Fig. S9 A and B) and more frequent α-DM1 CAG-Gln staining in leukocytes (10.68 ± 3.66%) (Fig. S9C) . The DM1 polyGln aggregates colocalize with caspase-8 ( Fig.  S9D ), which is an early indicator of polyGln-induced apoptosis (19) . Immunohistochemical staining of paraffin-embedded tissue with the polyGln-specific 1C2 antibody confirms staining in leukocytes in cardiac tissue from mice containing a CTG expansion of 55 repeats but not in control mice with 20 CTG repeats ( CTG·CAG repeats) (Fig. 6H) and skeletal muscle and at higher frequency in blood (Fig. S10) .
Discussion
Our understanding of the molecular basis of disease has been built on studying the expected effects of mutations on the functions of their corresponding genes. For microsatellite expansion disorders, cell culture and animal models have been developed to test specific hypotheses based on the prediction that CAG EXP mutations located in polyGln ORFs express protein only in the polyGln frame and that expansions located in noncoding regions do not encode proteins (2, 3) . We demonstrate that these canonical rules of translation do not apply for CAG·CTG expansions and that in the absence of an ATG codon expanded CAG and CTG trinucleotide repeats often express homopolymeric expansion proteins in all three frames. RAN translation occurs in transfected and transduced HEK293T and N2a cells. In contrast, non-ATG translation is less frequent in RRLs, suggesting that RRLs may not recapitulate what is happening inside cells. The production of polyGln protein after RNA transfections in cells indicates that cellular factors and not promoter issues affect RAN translation.
While initiation at specific alternative codons has been reported previously (16, 20) , our findings show translational initiation at CAG·CTG expansion sites in cells is highly permissive. Data showing that hairpin-forming CAG and CUG repeats undergo RAN translation are consistent with previous reports that hairpin structures affect translational initiation (20) . Hairpin structures are thought to allow translational initiation at suboptimal sites by delaying the 40S ribosomal subunit long enough to allow efficient interaction between the Met-tRNA i anticodon and the AUG or non-AUG start site (21) . Additionally, hairpins can recruit initiation factors and ribosomal subunits to internal ribosome entry sites (IRESs) (1) . Some IRESs, such as the one in the cricket paralysis virus, can facilitate translation initiation without eIFs or tRNA i
Met (1) . These IRES hairpins function as a tRNA i Met to initiate translation at non-AUG codons including GCA (22) . This function could explain why translation in the polyAla (GCA) frame appears to initiate at multiple sites within the repeat. IRES hairpins form and are stabilized with the help of IRES translation-associated factors (ITAFs) (1) , and at least one ITAF (CUGBP1) is known to bind to CAG and CUG repeats (23) . The apparent requirement for hairpins, the initiation from non-AUG codons, and the association of repeat transcripts with a known ITAF suggests that RAN translation may involve an IRES-like mechanism. Differences in repeat length required for the accumulation of polyGln, polyAla, and polySer proteins may reflect differences in protein stability and/or repeat length required for efficient initiation in each frame.
The discovery of RAN translation raises the possibility that polyAla and polySer proteins contribute to the pathogenesis of some of CAG polyGln diseases and that homopolymeric proteins contribute to diseases previously thought to involve primarily RNA gain of function (e.g., DM1). In SCA8, specific staining for the SCA8 GCA-Ala expansion protein is found in cerebellar Purkinje cells. In DM1, staining for the DM1 CAG-Gln expansion protein is found in heart, skeletal muscle, and myoblasts. Further investigation will be required to determine which microsatellite expansions undergo RAN translation and which RAN-translated proteins contribute to disease. Our results indicate polyAla and polySer proteins are more likely to be expressed from CAG·CTG expansions exceeding 70 repeats, suggesting the possibility that RAN-translated proteins may contribute to the anticipation, the earlier onset, and increased disease severity associated with longer repeat lengths.
Recently, much of the genome (24) and a growing number of expansion mutations (25) have been shown to be transcribed bidirectionally. Given that CAG EXP and CUG EXP transcripts can express proteins without an ATG, and that both expansion transcripts are reported to cause RNA gain-of-function effects (6, 25) , the molecular pathology of microsatellite disorders may be far more complex than currently appreciated. Additionally, these results raise the possibility that other repetitive sequences in the genome also undergo RAN translation and contribute to proteome diversity.
Materials and Methods
Details of cloning, custom antibodies, and molecular techniques are available in SI Materials and Methods. 
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Zu et al. 10 .1073/pnas.1013343108 SI Materials and Methods cDNA Constructs. The ATXN8 minigene (A8)(*KMQ EXP )-endo construct was generated by subcloning spinocerebellar ataxia type 8 (SCA8) cDNA into a pcDNA3.1 vector in the CAG direction. The SCA8 locus containing the CAG repeat expansion was amplified by PCR from the bacterial artificial chromosome (BAC) transgene construct BAC-Exp (1)1 using the 5′ primer (5′-CGAACCAAGCTTATCCCAATTCCTTGGCTAGACCC-3′) containing an added HindIII restriction site and the 3′ primer (5′-ACCTGCTCTAGATAAATTCTTA AGTAAGAGATAA-GC-3′) containing an added XbaI restriction site. The HindIII/ XbaI PCR product was cloned into the pcDNA3.1/myc-His A vector (Invitrogen) in the CAG orientation and placed under the control of the CMV promoter. The ATG start codon in the polyglutamine (polyGln) frame was mutated into AAG to remove the existing ORF and generate the A8(*KKQ EXP )-endo construct. To generate the A8(*KMQ EXP )-3Tf1, A8(*KKQ EXP )-3Tf1, A8(*KKQ EXP )-3Tf2, and A8(*KKQ EXP )-3Tf3 constructs, the HindIII/XbaI fragment was subcloned into pcDNA3.1/ 6Stops-3T vector. Stop codons between the 3′ end of the repeat and the tags were removed subsequently. In the resulting constructs, six stop codons (two for each frame) were placed prior to the 5′ end of the fragment, and each of three reading frames [polyGln, polyalanine (polyAla), and polyserine (polySer)] was tagged with myc-His, HA, and Flag epitopes, respectively. The ATT(CAG EXP )-3T construct was made by inserting the PCR fragment containing a pure CAG repeat into the pcDNA3.1/ 6Stops-3T vector. This construct contains a very limited sequence (5′-TAGAATT-CAG-3′) between the stop codon cassette and the CAG repeat tract. To remove the sequence between the last 5′ stop codon and the CAG repeat, the ATT (CAG EXP )-3T construct was digested with EcoRI, treated with mung bean nuclease, and ligated generating the TAG(CAG EXP )-3T construct, in which the last 5′ stop codon (TAG) is placed immediately upstream of CAG repeats, eliminating the existence of upstream alternative translation initiation. To generate the TAAG(CAG EXP )-3T construct, PCR was carried out using the 5′ primer (5′-AGTTAAGCTAGCTTAGCTAGGTAACTAAG-TAACTAGAATTAA-3′) and the 3′ primer (5′-TAGAAGGC-ACAGTCGAGGCTGATCA GCGGGTTT-3′). The PCR product was subcloned into the pcDNA3.1/6Stops-3T vector. To generate the TAGAG(CAG EXP )-3T construct, PCR was carried out using the 5′ primer (5′-AGTTAAGCTAGCTTAGCTA-GGTAACTAAGTAACTAGAATAGAGCA-3') and the 3′ primer (5′-TAGAAGGCACAGTCGAGGCTGATCAGCGG-GTTT-3′). The resulting product was subcloned into the pcDNA3.1/6Stops-3T vector. The Huntingtin (HD)-3T, Huntingtin-like 2 (HDL2)-3T, spinocerebellar ataxia type 3 (SCA3)-3T, and myotonic dystrophy type 1 (DM1)-3T constructs were made by inserting the duplex primers containing 20 nt 5′ of the CAG repeats from HD, HDL2, SCA3, and DM1 into the EcoRI site of the ATT(CAG EXP )-3T construct. The extra nucleotides between the 5′ flanking sequence (HD, HDL2, SCA3, and DM1) and CAG repeats were removed by digesting with EcoRI and another restriction site on the duplex primers, followed by treatment with mung bean nuclease and DNA ligase.
The NheI/PmeI fragments of A8(*KMQ EXP )-3Tf1, HD-3T, HDL2-3T, SCA3-3T, and DM1-3T constructs containing six stop codons, expanded CAG repeats, and three tags were subcloned into the lentiviral vector, CSII.
The ATG-V5(CAG 105 )-3T construct was created by inserting an oligo (5′-GAATTATGGGTAAGCCTATCCCTAACCCTC-TCCTCGGTCTCGATTCTACGGGA -3′ and 5′-ATTCCCGT-AGAATCGAGACCGAGGAGAGGGTTAGGGATAGGCT-TACCCAT-3′) containing a V5 tag at the 5′ end of the ATT (CAG EXP )-3T construct. The QuickChange II XL Site-Directed Mutagenesis Kit (Stratagene) was used to change the ATG in front of the V5 tag to an ATC to generate the ATC-V5-(CAG 105 )-3T construct which contains no ORFs.
To generate the CAA EXP constructs, a CAA repeat was amplified by PCR using the ACA 13 and TTG 15 primers. PCR products varied in size. A gel slice containing 200-to 550-bp fragments (67−183 repeats) was purified, and the resulting fragments were cloned into the pSC-A-amp/kan vector using Strataclone PCR Cloning Kit (Stratagene). Clones were sequenced, and desirable CAA repeats were excised and subcloned into pcDNA3.1/6Stops-3T. The resulting constructs were sequenced and CAA 125 (−ATG), CAA 90 (−ATG), and CAA 38 (−ATG) constructs were obtained. Modified versions of these constructs containing an ATG in the polyGln frame [CAA 125 (+ATG), CAA 90 (+ATG), and CAA 38 (+ATG)] were created using sitedirected mutagenesis (Stratagene).
To generate CTG EXP (Cys-myc/His), CTG EXP (Ala-myc/His), and CTG EXP (leucine-myc/His) constructs, a fragment of expanded CTG repeats was subcloned into pcDNA3.1/myc-His (A, B, and C respectively), and each of the three reading frames was C-terminally tagged. In the three resulting constructs, there is no ORF in each of three frames, and polyC, polyAla, and polyleucine are tagged individually in frame with an myc-His tag.
The 3′ flanking sequence of DM1 in the CAG direction was amplified by PCR using 5′ primer (5′-CTCGAGGCTACAAG-GACCCTTCGAG-3′) and 3′ primer (5′-CCTGAACCCTAGA-ACTGTCTTCGACT-3′) and was cloned into a PCR cloning vector, pCR4-TOPO (Invitrogen). The XhoI/PmeI fragment of pCR4-DM1-3′ was subcloned downstream of CAG repeats of ATT (CAG EXP )-3T to generate the CAG-DM1-3′ construct containing expanded CAG repeats and the 3′ flanking sequence of DM1.
PCR-mediated mutagenesis was used to create several constructs in which the ATT or ATC alternative start codons were altered to ACT and ACC, respectively. All constructs were created using the 3′ primer (5′-TAGAAGGCACAGTCGA-GGCTGATCAG CGGGTTT-3′) and a unique 5′ primer. The ACT (CAG 105 The IntR(CAG EXP )-3T construct was made by inserting the duplex primer containing (CAG) 18 CGCGCG into the EcoRI site of the ATT(CAG 69 )-3T construct. The extra nucleotides between (CAG) 18 CGCGCG and (CAG) 69 were removed by digestion with EcoRI, followed by treatment with mung bean nuclease and DNA ligase.
All PCR reactions to generate the above constructs were performed with Pfx polymerase (#11708-013; Invitrogen) to mitigate PCR-induced mutations. The above PCR products were digested with HindIII and PmeI, gel purified, and cloned into pcDNA3.1 containing the 6X STOP cassette. The integrity of all constructs was confirmed by sequencing.
Production of Polyclonal Antibodies. The polyclonal antibodies were generated by New England Peptide. The α-SCA8 GCA-Ala antisera were raised against a synthetic peptide corresponding to the C terminus of the predicted polyAla frame of SCA8 in the CAG direction (VKPGFLT). The α-DM1 CAG-Gln antisera were raised against a synthetic peptide corresponding to the C terminus of a predicted glutamine frame of DM1 in the CAG direction (SPAARGRARITGLEL).
Cell Culture and Transfection. HEK293T cells were cultured in DMEM supplemented with 10% fetal bovine serum and incubated at 37°C in a humid atmosphere containing 5% CO 2 . DNA transfections were performed using Lipofectamine 2000 Reagent (Invitrogen) according to the manufacturer's instructions.
Murine neuroblastoma (N2a) cells were cultured in unsupplemented DMEM and incubated at 37°C in a humidified, 5% CO 2 incubator. DNA transfections were performed using TransITExpress (Mirus) according to the manufacturer's instructions.
DM1 patient myoblasts with 50-70 CTG repeats, along with a normal control, were cultured in skeletal muscle growth medium (SGM; PromoCell) with Glutamax (Invitrogen), gentamicin (50 units/mL), decomplemented fetal calf serum, and the provided supplemental mix. Cells were grown to approximately 70% confluence on collagen-coated coverslips in six-well tissue-culture plates.
RNA Transfections. Plasmid DNA was linearized using PvuII. Transcription, capping, and polyadenylation was performed using 1 μg of DNA with the mScript mRNA Production System (Epicentre). Transfections were performed in six-well plates using 3 μg mRNA and 10 μL Lipofectamine 2000 (Invitrogen) per well. Cell lysates were collected 18-24 h posttransfection, and immunoblots were performed as described.
Immunofluorescence. The subcellular distribution of homopolymer proteins was assessed in transfected HEK293T cells by immunofluorescence. Cells were cultured on coverslips in six-well tissue-culture plates and transfected with plasmids the next day. Forty-eight hours posttransfection, cells were fixed in 4% paraformaldehyde in PBS for 30 min and permeabilized in 0.5% Triton X-100 in PBS for 10 min. The coverslips were blocked in 1% normal goat serum (NGS) in PBS for 30 min. After blocking, the cells were incubated for 1 h at 37°C in blocking solution containing the rabbit anti-His (1:100), rat anti-HA (1:100), and mouse anti-Flag (1:200) primary antibodies. The coverslips were washed three times in PBS and incubated for 1 h at 37°C in blocking solution containing secondary antibodies. Goat antirabbit conjugated to Cy3 (Jackson ImmunoResearch), goat antirat conjugated to Cys5 (Jackson ImmunoResearch), and goat anti-mouse conjugated to Alexa Fluor 488 (Invitrogen) were used at a dilution of 1:200.
DM1 patient myoblasts grown on coverslips were fixed in 4% paraformaldehyde for 30 min and blocked with 5% NGS for 1 h. Next, the cells were incubated with α-DM1 CAG-Gln) (1:5,000) at 4°C overnight. Cells then were washed and incubated with goat anti-rabbit conjugated to Cy3 (Jackson ImmunoResearch) for1 h at room temperature, in darkness. Slides were washed three times for 5 min in 1× PBS, mounted with Vectashield HardSet mounting medium with DAPI (Vector Laboratories, Inc.) and coverslipped.
For mouse and human tissues, 9-μm cryosections were fixed in 4% paraformaldehyde for 15 min. Heat-induced epitope retrieval (HIER) was employed by steaming sections in citrate buffer, pH 6.0, at 90°C for 20 min. HIER was used in all immunofluorescence tissue experiments except for SCA8 GCA-Ala mouse and human experiments in which antigen retrieval was omitted altogether. A nonserum block (Biocare Medical) was applied to all tissues (except the SCA8 mouse tissue in which 10% NGS in a 0.3% Triton X-100 was used to block nonspecific immunoglobulin binding) and was allowed to incubate at room temperature for 1 h. The primary antibody (or antibodies, if double-or triple-labeled) was diluted either in a 1:5 solution of the nonserum block or in a solution of 5% NGS in PBS containing 0.3% Triton X-100 and was incubated at 4°C overnight. Tissues then were incubated for 1 h in a 1:2,000 dilution of IgG-TRITC, in the dark at room temperature. If needed, a Sudanblack autofluorescence block was applied to the tissue for 1 h at room temperature in the dark (2). Staining was observed, and pictures were taken on an Olympus FluoView 1000 I×2 inverted confocal microscope. All mutant and control images were adjusted in unison, to the same specifications, and in a linear fashion, for intensity and contrast when deemed necessary.
Quantitative Imaging. Cells were counted using Image-Pro Plus 6.0 (Media Cybernetics) using an automatic dark-object count method. Images first were digitally annotated by a pathologist to separate coagulated blood from cardiac myocytes into distinct regions of interest. The images were split into grayscale versions of their blue color channel (nuclear stain color) and red color channel (positive marker color). The grayscale images were analyzed in each region of interest with Image-Pro Plus using a dark-object count method with automatic thresholding for nuclear intensity.
Immunohistochemistry. Myotonic dystrophy (DM) mutant and control mice were perfused in 10% formalin, and tissue was harvested and embedded in paraffin. Five-micrometer sections were deparaffinized in xylene and rehydrated through graded alcohol, incubated with 90% formic acid for 5 min, and washed with distilled water for 30 min. HIER was performed by steaming sections in citrate buffer, pH 6.0, at 90°C for 20 min. To block nonspecific avidin-D/biotin binding, the Avidin-D/Biotin block (Vector Laboratories, Inc.) was used as described. To block nonspecific immunoglobulin binding, a nonserum block (Biocare Medical) was applied for 30 min. Primary 1C2 antibody was applied at a dilution of 1/12,000 in nonserum block (Biocare Medical) and incubated overnight at 4 o C. Biotinylated secondary α-mouse IgG purified in goat (Vector Laboratories, Inc.) was applied at a dilution of 1:200 for 30 min at room temperature. ABC reagent (Vector Laboratories, Inc.) was used for detection with Chromagen SG (Vector Laboratories, Inc.) for 10 min and counterstained with nuclear fast red.
Leukocyte cell pellets were isolated from peripheral blood of DM1 patients and controls. The cell pellets were fixed in 10% neutral buffered formalin for 30 min, washed, encapsulated in HistoGel (Richard-Allen), and placed in 70% ethanol. The pellets then underwent a short, 2-h cycle in the tissue processor and were embedded in paraffin blocks. Five-micrometer sections were cut, deparaffinized, and hydrated to water. HIER was employed with steam and Reveal Decloaker (Biocare Medical). A nonserum block (Biocare Medical) was applied for 30 min to prevent nonspecific immunoglobulin binding. The nonserum block 1:10 in PBS was used to dilute the α-DM1 CAG-Gln) antibody to a concentration of 1:10,000. Slides were incubated overnight at 4°C and washed three times for 5 min in PBS. The secondary antibody, DyLight 488-conjugated AffiniPure goat anti-rabbit (Jackson Immunoresearch) was applied and incubated for 2 h in the dark at room temperature at a concentration of 1:1,000. Slides were washed three times for 5 min in PBS, mounted with Vectashield HardSet Mounting Medium with DAPI (Vector Laboratories, Inc.), and coverslipped. Staining was observed, and pictures were taken on an Olympus FluoView 1000 I×2 inverted confocal microscope. For consistency in Fig. S10C , Olympus FluoView software was used to reassign the green 488λ captured signal to red.
Cell Death Analysis. N2a cells were transfected with CAG 105 and CAA 90 (control) constructs with or without ATG initiation codons and were grown in DMEM without FBS. After 48 h, cells were stained with annexin-V to detect phosphatidylserine (an early marker of apoptosis) on the plasma membrane and were sorted by flow cytometry. For flow cytometric annexin-V analysis, floating cells were collected and combined with trypsinized, adherent cells in ice-cold PBS supplemented with 2% FBS. After washing, cells were resuspended in annexin-binding buffer (BD Biosciences), vortexed, and stained with annexin-V-APC (BD Biosciences) according to manufacturer's instructions. Cells were placed on ice and sorted immediately on a BD FACScalibur flow cytometer. Thirty thousand total events were collected. Two independent experiments, each done in triplicate, were performed, and data were combined and normalized to the ATT(CAA 90 ) average. Statistics were performed using a one-way ANOVA, F(3, 20) = 0.07, P = 0.0003, and post hoc P values were calculated with a one-tailed t-test. ]-serine was added to the respective wells at 25 μCi/mL, and the cells were incubated for 16 h at 37°C. Cells in culture plates were rinsed with PBS and lysed in RIPA buffer [150 mM NaC1, 1% sodium deoxycholate, 1% Triton X-100, 50 mM Tris-HC1 (pH 7.5), 1× protease inhibitors (Roche)] for 45 min on ice. The cell lysates were centrifuged at 16,000 × g for 15 min at 4°C, and the supernatant was collected. To immunoprecipitate 3 H-labeled protein, 500 μg of tissue lysate was incubated with the desired antibody at 4°C for 2 h and then with protein G-Sepharose at 4°C overnight. Protein G-Sepharose was washed three times with RIPA buffer. Bound proteins were eluted from the beads with 1× SDS sample buffer, incubated at 90°C for 10 min, and analyzed by protein gel electrophoresis. 35 S]methionyl-tRNA i Met was added at a concentration of 100 μg/mL for in vitro translation using a T7-coupled transcription and translation kit. The reaction products were analyzed as described above.
Immunoprecipitation. The protein concentration of tissue lysates was determined using the protein assay dye reagent (Bio-Rad). To immunoprecipitate polyGln protein, 500 μg of tissue lysate was incubated with rabbit polyclonal anti-His antibody at 4°C for 2 h and then with protein G-Sepharose at 4°C for overnight. Protein G-Sepharose was washed three times with RIPA buffer. Bound proteins were eluted from the beads with 1× SDS sample buffer, incubated at 90°C for 10 min, and analyzed by immunoblotting.
Immunoblotting. Cells in each well of a six-well tissue-culture plate were rinsed with PBS and lysed in 300 μL RIPA buffer for 45 min on ice. DNA was sheared by passage through a 21-gauge needle. The cell lysates were centrifuged at 16,000 × g for 15 min at 4°C, and the supernatant was collected. The protein concentration of the cell lysate was determined using the protein assay dye reagent (Bio-Rad). Twenty micrograms of protein were separated in a 4-12% or 10% NuPAGE Bis-Tris gel (Invitrogen) and transferred to a nitrocellulose membrane (Amersham). The membrane was blocked in 5% dry milk in PBS containing 0.05% Tween-20 and probed with the anti-His antibody (1:500) or 1C2 antibody (1:1,000) in blocking solution. After the membrane was incubated with anti-rabbit or anti-mouse HRP-conjugated secondary antibody (Amersham), bands were visualized by the ECL plus Western Blotting Detection System (Amersham).
The distinctive migration pattern of the polyAla may result from initiation at multiple sites and/or the formation of higher molecular weight protein complexes resistant to dissociation in SDS and 8 M urea. The polySer proteins might undergo beta elimination and addition from side chains of another polymer to create 3D-crosslinked polypeptides that would be extremely large (4).
MS.
To immunoprecipitate polyAla protein for MS, transfected HEK293T cell lysate from five 150-mm dishes was incubated with mouse monoclonal antibody against the C-terminal HA tag at 4°C for 2 h and then with protein G-Sepharose at 4°C overnight. Protein G-Sepharose was washed three times with RIPA buffer. Bound proteins were eluted from the beads with 8 M urea. Samples were separated by parallel SDS-PAGE 4-15% Criterion Tris-HCl gels (Bio-RAD), one for MS and the other for immunoblotting. Protein bands of interest were excised manually after visualizion with Imperial Protein Stain (Thermo Scientific). Specified bands were cut out and subjected to in-gel trypsin digestion using standard methods (5), and extracted peptides were cleaned up further using "stage" tips (6). Mass analysis was performed using an LTQ-Orbitrap XL mass spectrometer (Thermo Scientific). Peptides derived from in-gel digestion were separated by reversed-phase chromatography with nanoHPLC. The gradient was 2-40% acetonitrile in H 2 O containing 0.1% formic acid for more thn 60 min. Full MS scans were generated in the orbital trap at 60,000 resolution for 400 m/z. MS/MS scans were performed in a data-dependent manner using an inclusion list based on predicted tryptic peptides in the LTQ ion trap using collision induced dissociation (CID). Data were searched with SEQUEST V27 with semi-trypsin specificity, cysteine carbamidomethylation as a fixed modification, and N-terminal methionine oxidation as a variable modification. The search was performed against the combined database consisting of the National Center for Biotechnology Information human database V200906 and its reversed complement and an additional list of all possible proteins that could be initiated anywhere in the polyAla frame of the IntR (CAG EXP )-3T construct with or without an N-terminal methionine, which totaled >76,000 entries. Identified proteins were organized using Scaffold (www.proteomesoftware.com), and peptide probabilities were calculated within this program using Peptide Prophet (7). The identification output was filtered using a precursor mass tolerance at 7 ppm.
In Vitro Translation. In vitro translation was performed using coupled reticulocyte lysate systems (Promega). Coupled transcription/translation reactions (50 μL) contained 50% lysate, 1 μL T7 RNA polymerase, 20 μM amino acid mixtures, 1 μL (40 units) RNasin ribonuclease inhibitor (Promega), and 1 μg plasmid DNA. Incubation was performed at 30°C for 90 min. Ten percent of each reaction was analyzed by Western blotting.
Production and Purification of Lentiviral Vectors and Transduction of HEK293T Cells. HEK293T cells were plated on 150-mm tissueculture dishes and transfected the following day when cells were 80-90% confluent. Thirty micrograms of the transducing vector, 20 μg of the packaging vector ΔNRF, and 10 μg of the VSV envelope pMD.D were cotransfected by calcium phosphatemediated transfection. The medium was changed the next day, and conditioned media were collected 48 and 72 h after transfection. Conditional medium then was cleared by filtering through a 0.45-μm filter. The viral particles were concentrated by ultracentrifugation at 50,000 × g for 2 h. The pellet was resuspended in 20 μL of 1× HBSS and stored at −70°C. HEK293T cells were seeded into each well of a six-well plate and transduced the next day. Transduced cells were analyzed by Western blotting after 5 d.
Injection of Mouse Brain with Lentiviral Vectors. Six-week-old FVB mice were anesthetized by intramuscular injection using a combination of ketamine and xylazine. Two microliters of lentiviral vectors [5 × 10 9 functional viral titer (TU)/mL] were injected into mouse striatum and cerebellum. The mouse was mounted in a stereotactic frame, and its head was shaved. A midline sagittal incision was made, and the cranium was exposed. For each injection site, a burr hole was drilled, and a Hamilton syringe was inserted to the depth described below the dura, plus an additional 0.5 mm. After 2 min, the syringe was retracted 0.5 mm to form a slight pocket in the parenchyma. After a pause of at least 2 min for pressure equalization, the injection was performed manually at an approximate rate of 0.5 μL/min. The syringe was left in place for an additional 3 min after injection and then was withdrawn over a period of 2 min or more. Once injections were complete, the scalp was sutured; the mouse was kept under a warming lamp until it recovered from the anesthesia and then was returned to standard housing. Animal care followed the guidelines set by the Institutional Animal Care and Use Committee at the University of Minnesota.
Polysome Profiling. Transfected HEK293T cells in 150-mm dishes were treated with cycloheximide (100 μg/mL) for 5 min and harvested by trypsinization. The cell pellet was resuspended in 375 μL of low-salt buffer [10 mM NaCl, 20 mM Tris (pH 7.5), 3 mM MgCl 2 , 1 mM DTT, and 200 units RNAse inhibitor) and allowed to swell for 2 min. Then 125 μL lysis buffer (0.2 M sucrose, 1.2% Triton X-100 in low-salt buffer) was added, and the cells were homogenized using 15 strokes in a Dounce homogenizer using the tight-fitting pestle. Lysate was centrifuged at 16,000 × g for 1 min, and the nuclear pellet was removed. Cytoplasmic extract (1.5 mg measured at A 260 ) was layered onto a 5-mL, 0.5-1.5 M sucrose gradient and centrifuged at 200,000 × g in a Beckman SW50 rotor for 80 min at 4°C. The gradients were fractionated using an ISCO density gradient fractionator monitoring absorbance at 254 nm. Ten fractions from each sample were collected into tubes containing 50 μL of 10% SDS.
Northern Analysis. The RNA from each fraction of the sucrose gradient was extracted using Tri-reagent (Sigma). For Northern blot analysis, an equal volume of the RNA from each fraction was separated on a glyoxal gel, blotted to a nylon membrane, and probed with a [ 32 P]ATP-labeled oligonucleotide (5′-TAGAAG-GCACAGTCGAGGCTGATCAGCGGGTTTAAACTCAAT-3′) complementary to the 3′ end of the CAG-containing transcripts. Blots subsequently were probed with a [ 32 P]dATP-labeled GAPDH cDNA probe.
RT-PCR. For detection of CAG and CAA expansion transcripts, cells were transfected using Lipofectamine 2000 (Invitrogen) as described above. RNA and protein were harvested using Trizol (Invitrogen). Approximately 45 μg of RNA from each sample was resuspended in 50 μL diethylpyrocarbonate distilled water. The RNA sample was treated with an RNase-free DNase Set (Qiagen) and the RNeasy Plus Mini Kit (Qiagen) to remove DNA. A Superscript II Reverse Transcriptase System (Invitrogen) and the Myc Tag GSP Primer (5′-CAGATCCTCTTCTGAGATGAGT-TTTTGTTC-3′) were used to reverse transcribe the RNA, and PCR was performed using the 336 forward (5′-ACCCAAGCTG-GCTAGTTAAGC-3′) and 336 reverse (5′-TGTCGTCGTCG-TCCTTGTAA-3′) primers at 95°C for 2 min, then 35 cycles of 94°C for 45 s, 59.5°C for 30 s, 72°C for 45 s, and a 6-min extension at 72°C. Control reactions were performed using the β-actin forward (5′-TCGTGCGTGACATTAAGGAG-3′) and β-actin reverse (5′-GATCTTCATTGTGCTGGGTG-3′) primers. PCR conditions were 95°C for 2 min, then 35 cycles of 94°C for 45 s, 59.5°C for 30 s, 72C for 45 s, followed by a 6-min final extension at 72°C. PCR products were separated on a 1% agarose gel. For detection of CAG expansion transcripts in DM humans and mice, total RNA was extracted from frozen tissues with Trizol (Invitrogen) following incubation with lysis buffer and 0.5 mg/mL proteinase K, as well as precipitation and DNAse treatment. For strand-specific RT-PCR, a linker sequence (lk) was attached (5′-CGACTGGAGCAC-GAGGACACTGA-3′) to the 5′ end of primers specific for the antisense strand of dystrophia myotonica-protein kinase (DMPK): (i) 5′-CGCCTGCCAGTTCACAACCGCTCCGAGCGT-3′ or (ii) 5′-GACCATTTCTTTCTTTCGGCCAGGCTGAGGC-3′. Three micrograms of RNA were reverse-transcribed with Superscript III (Invitrogen) at 55°C. PCR against the anti1B, antiN3, and antiA2 regions was carried out using the CTCF1b (5′-GCAGCATT-CCCGGCTACAAGGACCCTTC-3′), antiN3 (5′-GAGCAGGG-CGTCATGCACAAG-3′) and the antiA2 (5′-TAGGTGGGGA-CAGACAAT -3′) primers, respectively. The linker primer was used in all reactions. The PCR reactions were done using the following conditions: antiB1, 94°C for 5 min, then 30 cycles of 94°C for 30 s, 67°C for 30 s, and 72°C for 1 min followed by 10 min at 72°C; antiN3, 94°C for 5 min, then 30 cycles of 94°C for 30 s, 63°C for 30 s and 72°C for 1 min followed by 10 min at 72°C ; antiA2, 94°C for 5 min, then 40 cycles of 94°C for 30 s, 57°C for 30 s, and 72°C for 1 min followed by 10 min at 72°C. GAPDH was amplified using the GFw (5′-AGGTCGGTGTGAACGGATTTG-3′) and GRev (5′-TGTAGACCATGTAGTTGAGGTCA-3′) primers at 94°C for 5 min and then 24 cycles of 94°C for 30 s, 65C for 30 s, and 72°C for 1 min followed by 10 min at 72°C. 
